| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1030715253 |
| P356 | DOI | 10.1186/1471-2164-8-318 |
| P932 | PMC publication ID | 2075524 |
| P698 | PubMed publication ID | 17845732 |
| P5875 | ResearchGate publication ID | 5994258 |
| P2093 | author name string | Heidrun Brandt | |
| Rainer Hofmann | |||
| Gerhard Aumüller | |||
| Lutz Konrad | |||
| Ansgar Schmidt | |||
| Elke Völck-Badouin | |||
| Jonas A Scheiber | |||
| Leslie Laible | |||
| Marcel M Keilani | |||
| P2860 | cites work | Human transforming growth factor type beta 2: production by a prostatic adenocarcinoma cell line, purification, and initial characterization | Q68766834 |
| Differential effects of transforming growth factor beta on human prostate cancer cells in vitro | Q69351975 | ||
| Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells | Q70866425 | ||
| A human transforming growth factor-beta type II receptor that contains an insertion in the extracellular domain | Q71090132 | ||
| Alternative splicing within the TGF-beta type I receptor gene (ALK-5) generates two major functional isoforms in vascular smooth muscle cells | Q73422801 | ||
| Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation | Q73496643 | ||
| Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy | Q73959218 | ||
| Analysis of the mRNA expression of the TGF-Beta family in testicular cells and localization of the splice variant TGF-beta2B in testis | Q79991870 | ||
| Diversity and modulation of plasminogen activator activity in human prostate carcinoma cell lines | Q93863628 | ||
| Cloning of a cDNA encoding the human transforming growth factor-beta type II receptor: heterogeneity of the mRNA | Q28116060 | ||
| Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease | Q28202655 | ||
| Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction | Q28284617 | ||
| Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice | Q28361871 | ||
| Heart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos | Q28508310 | ||
| TGFβ2 knockout mice have multiple developmental defects that are non-overlapping with other TGFβ knockout phenotypes | Q28592444 | ||
| Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice | Q28594495 | ||
| TGF-beta signaling in tumor suppression and cancer progression | Q29615427 | ||
| A genomic view of alternative splicing | Q29615892 | ||
| Predicting splice variant from DNA chip expression data | Q30655443 | ||
| Truncation of the TGF-beta type II receptor gene results in insensitivity to TGF-beta in human gastric cancer cells | Q30699198 | ||
| Inferring alternative splicing patterns in mouse from a full-length cDNA library and microarray data | Q30713065 | ||
| High frequency of serum DNA alterations in renal cell carcinoma detected by fluorescent microsatellite analysis | Q30831493 | ||
| ASDB: database of alternatively spliced genes | Q33610198 | ||
| Alternative splicing and genome complexity | Q33956410 | ||
| Protein diversity from alternative splicing: a challenge for bioinformatics and post-genome biology | Q34084341 | ||
| Latency, activation, and binding proteins of TGF-beta | Q34136471 | ||
| Structural and sequence analysis of TGF-beta 2 cDNA clones predicts two different precursor proteins produced by alternative mRNA splicing | Q34556702 | ||
| Alternative splicing: multiple control mechanisms and involvement in human disease | Q34586931 | ||
| Integration of the TGF-beta pathway into the cellular signalling network | Q34929949 | ||
| ASAP: the Alternative Splicing Annotation Project | Q35158228 | ||
| Functions and regulation of transforming growth factor-beta (TGF-beta) in the prostate | Q36088804 | ||
| Cloning of an isoform of mouse TGF-beta type II receptor gene. | Q36726542 | ||
| Molecular cloning of a mouse counterpart for human TGF-beta type I receptor | Q36743213 | ||
| Transforming growth factor-beta 3 is required for secondary palate fusion | Q37373842 | ||
| Tissue expression of transforming growth factor-beta1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy | Q38447431 | ||
| EASED: Extended Alternatively Spliced EST Database | Q40403653 | ||
| In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2. | Q40583089 | ||
| The role of transforming growth factor-beta and its receptors in human prostate smooth muscle cell fibronectin production | Q40795836 | ||
| Cell lineage characteristics of human prostatic stromal cells cultured in vitro | Q40892591 | ||
| Regulation of prostatic stromal cell growth and function by transforming growth factor beta (TGFbeta). | Q40930461 | ||
| Fibronectin in human prostatic cells in vivo and in vitro: expression, distribution, and pathological significance | Q40933445 | ||
| Prostate specific membrane antigen (PSM) is expressed in various human tissues: implication for the use of PSM reverse transcription polymerase chain reaction to detect hematogenous prostate cancer spread | Q40965186 | ||
| The conventional transforming growth factor-beta (TGF-beta) receptor type I is not required for TGF-beta 1 signaling in a human prostate cancer cell line, LNCaP. | Q41032532 | ||
| Comparative studies of the mitogenic effects of epidermal growth factor and transforming growth factor-alpha and the expression of various growth factors in neoplastic and non-neoplastic prostatic cell lines | Q41123032 | ||
| Differential gene expression of transforming growth factors alpha and beta, epidermal growth factor, keratinocyte growth factor, and their receptors in fetal and adult human prostatic tissues and cancer cell lines | Q41147991 | ||
| TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis | Q41159403 | ||
| Expression of Recombinant TGF-β2(442) Precursor and Detection in BSC-40 Cells | Q41699785 | ||
| Alterations of expression and regulation of transforming growth factor beta in human cancer prostate cell lines | Q42437180 | ||
| Isolation and molecular characterization of the porcine transforming growth factor beta type I receptor (TGFBR1) gene | Q42597291 | ||
| Alternative splicing in the human, mouse and rat genomes is associated with an increased frequency of exon creation and/or loss | Q46234594 | ||
| The expression and structure of TGF-beta2 transcripts in rat muscles | Q47844964 | ||
| cDNA cloning of porcine transforming growth factor-beta 1 mRNAs. Evidence for alternate splicing and polyadenylation. | Q48309411 | ||
| Expression and function of TbetaRII-B, a variant of the type II TGF-beta receptor, in human chondrocytes. | Q54566748 | ||
| Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptor | Q24290737 | ||
| Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death | Q24563654 | ||
| Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer | Q27860572 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | alternative mRNA splicing, via spliceosome | Q21114084 |
| P304 | page(s) | 318 | |
| P577 | publication date | 2007-09-11 | |
| P1433 | published in | BMC Genomics | Q15765854 |
| P1476 | title | Alternative splicing of TGF-betas and their high-affinity receptors T beta RI, T beta RII and T beta RIII (betaglycan) reveal new variants in human prostatic cells | |
| P478 | volume | 8 |
| Q30495758 | Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant |
| Q37733021 | Clusterin signals via ApoER2/VLDLR and induces meiosis of male germ cells |
| Q49383907 | Composition of the Stroma in the Human Endometrium and Endometriosis |
| Q33967539 | Crosstalk between the p38 and TGF-β signaling pathways through TβRI, TβRII and Smad3 expression in plancental choriocarcinoma JEG-3 cells |
| Q42474780 | Distribution of mRNAs encoding transforming growth factors-beta1, -2, and -3 in the intact rat brain and after experimentally induced focal ischemia |
| Q41668059 | Diverse effects of ANXA7 and p53 on LNCaP prostate cancer cells are associated with regulation of SGK1 transcription and phosphorylation of the SGK1 target FOXO3A |
| Q38171229 | Hallmarks of alternative splicing in cancer |
| Q100737131 | Hematopoietic stem and progenitor cell signaling in the niche |
| Q92564057 | In silico analysis of alternative splicing on drug-target gene interactions |
| Q84391919 | Reduced numbers of Sertoli, germ, and spermatogonial stem cells in impaired spermatogenesis |
| Q51040719 | TGFβ splicing and canonical pathway activation in high-grade serous carcinoma. |
| Q42709113 | The Drosophila Activin-like ligand Dawdle signals preferentially through one isoform of the Type-I receptor Baboon |
| Q34441994 | Time course, distribution and cell types of induction of transforming growth factor betas following middle cerebral artery occlusion in the rat brain |
| Q35788686 | Transcriptome Bioinformatical Analysis of Vertebrate Stages of Schistosoma japonicum Reveals Alternative Splicing Events |
Search more.